Skip navigation

Streamline Data Collection Processes to Enable Efficient CEC Review and Regulatory Submissions

May 2-3, 2017
  • Philadelphia, PA

The industry’s leading Endpoint Adjudication event is back! Heading into our 3rd year, we have seen record attendance as over 200 professionals from pharmaceutical, biotech, medical device and CRO industries have benefited from our event.

CBI’s 3rd Annual Endpoint Adjudication conference provides attendees with strategies to manage the complex adjudication process by offering practical insights for independent review committee selection and charter development as well as compiling information from various sources to provide consistent, reliable and accurate data to be submitted for adjudication.

Bring your team! In the past 2 years, 63% of attendees registered with a colleague.

What’s New in 2017?

  • Adjudicator panel comprised of various therapeutic expertise
  • Adjudication in pharma, device and diagnostic companies
  • Insight on how adjudicated data is used in clinical trial reports
  • Clarification of discrepancies in the adjudication data sets and an understanding of what makes a good database
  • Applied methods and operational process roadmaps to adjudication
  • Appropriate methodologies for handling quality control (QC) aspects of adjudication data
  • Tackling cost containment surrounding adjudication processes and clinical endpoint committees (CEC)
  • Auditability and preparedness for regulatory information

Buzz From the 2016 Event:

This is my second time attending and I was very impressed with all speakers. Great conference with a wealth of information on adjudication and CEC.

Assistant Oversight Committees PM, CPC Clinical Research

Superb meeting! Well run, good on-sight, useful topics for various skill levels. Thank you!

Director, Medical Safety, Integra LifeSciences

 

May 2-3, 2017 Hilton at Penn's Landing Philadelphia, PA

3rd Annual Endpoint Adjudication

Streamline Data Collection Processes to Enable Efficient CEC Review and Regulatory Submissions

The industry’s leading Endpoint Adjudication event is back! Heading into our 3rd year, we have seen record attendance as over 200 professionals from pharmaceutical, biotech, medical device and CRO industries have benefited from our event.

CBI’s 3rd Annual Endpoint Adjudication conference provides attendees with strategies to manage the complex adjudication process by offering practical insights for independent review committee selection and charter development as well as compiling information from various sources to provide consistent, reliable and accurate data to be submitted for adjudication.

Bring your team! In the past 2 years, 63% of attendees registered with a colleague.

What’s New in 2017?

  • Adjudicator panel comprised of various therapeutic expertise
  • Adjudication in pharma, device and diagnostic companies
  • Insight on how adjudicated data is used in clinical trial reports
  • Clarification of discrepancies in the adjudication data sets and an understanding of what makes a good database
  • Applied methods and operational process roadmaps to adjudication
  • Appropriate methodologies for handling quality control (QC) aspects of adjudication data
  • Tackling cost containment surrounding adjudication processes and clinical endpoint committees (CEC)
  • Auditability and preparedness for regulatory information

Buzz From the 2016 Event:

This is my second time attending and I was very impressed with all speakers. Great conference with a wealth of information on adjudication and CEC.

Assistant Oversight Committees PM, CPC Clinical Research

Superb meeting! Well run, good on-sight, useful topics for various skill levels. Thank you!

Director, Medical Safety, Integra LifeSciences

 

May 2-3, 2017 Hilton at Penn's Landing Philadelphia, PA